Company: BERG Health
Job title: Chief Precision Medicine Officer & Vice President, Systems Medicine
Michael is the Chief Precision Medicine Officer and VP of Systems Medicine at BERG, a Boston-based biopharma company driving next-generation drug and diagnostic development by combining patient-driven biology and Bayesian AI. He has pioneered novel phenomic strategies for biomarker, pharmaceutical, and theranostic development to embody the philosophy of treating the patient, not just the disease. These approaches have led to implementation of streamlined molecular adaptive clinical trials as well as diagnostic products for prostate cancer, pancreatic cancer, breast cancer, and Parkinson’s disease that are in development. Michael is also extensively involved with overseeing translational precision medicine strategies in partnership with the U.S. Department of Defense and several other domestic and international efforts. Michael received his Ph.D. from Boston College followed by extensive postdoctoral training at Washington University School of Medicine, where he mastered and implemented novel mass spectrometry-based OMICS platforms as well as a molecular therapeutic strategies for treatment of neurological, cardiovascular, and metabolic diseases. He has also authored more than 60 publications and book chapters.
4.45 | 1.45 Live Audience Q+A 4:35 pm
day: Day Two
4.15 | 1.15 Data, Data Everywhere and Not Enough Time to Think: Deploying a Bayesian Approach to Identify Causality in OMICS Data for Population Health & Precision Medicine 4:15 pm
day: Day Two